Safety and feasibility of adjunctive regadenoson injection at peak exercise during exercise myocardial perfusion imaging: The Both Exercise and Regadenoson Stress Test (BERST) trial

Journal of Nuclear Cardiology

Volumn 20, Issue 2, 2013, Pages 197-204

  Ross, M I ^a   Wu, E ^a   Wilkins, J T ^a   Gupta, D ^a   Shen, S ^a   Aulwes, D ^a   Montero, K ^a   Holly, T A ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

A2A adenosine receptor agonists; exercise: stress testing; myocardial perfusion imaging: SPECT; pharmacologic stress

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; REGADENOSON;

ADULT; ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DRUG SAFETY; ELECTROCARDIOGRAPHY; EXERCISE INTENSITY; FEASIBILITY STUDY; FEMALE; HEART BLOCK; HEART CATHETERIZATION; HEART RATE; HUMAN; HYPERTENSION; HYPOTENSION; IMAGE ANALYSIS; IMAGE PROCESSING; IMAGE QUALITY; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MYOCARDIAL PERFUSION IMAGING; PHARMACOLOGIC STRESS TESTING; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY DISTRESS; SINGLE DRUG DOSE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SPECT SCANNER; THORAX PAIN; TREADMILL EXERCISE;

ADENOSINE A2 RECEPTOR AGONISTS; ADULT; CORONARY ARTERY DISEASE; EXERCISE TEST; FEMALE; HUMANS; IMAGE ENHANCEMENT; MALE; MYOCARDIAL PERFUSION IMAGING; PHYSICAL ENDURANCE; PHYSICAL EXERTION; PURINES; PYRAZOLES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VASODILATOR AGENTS;

EID: 84879504159     PISSN: 10713581     EISSN: 15326551     Source Type: Journal    
DOI: 10.1007/s12350-013-9679-1     Document Type: Article

References (13)

1. Myers J, Prakash M, Froelicher V, Do D, Partington S, Atwood JE. Exercise capacity and mortality among men referred for exercise testing. N Engl J Med 2002;346:793-801.
2. Johnson NP, Wu E, Bonow RO, Holly TA. Relation of exercise capacity and body mass index to mortality in patients with intermediate to high risk of coronary artery disease. Am J Cardiol 2008;102:1028-33.
3. Casale PN, Guiney TE, Strauss HW, Boucher CA. Simultaneous low level treadmill exercise and intravenous dipyridamole stress thallium imaging. Am J Cardiol 1988;62:799-802.
4. Ignaszewski AP, McCormick LX, Heslip PG, McEwan AJ, Humen DP. Safety and clinical utility of combined intravenous dipyridamole/symptom-limited exercise stress test with thallium-201 imaging in patients with known or suspected coronary artery disease. J Nucl Med 1993;34:2053-61.
5. Holly TA, Satran A, Bromet DS, Mieres JH, Frey MJ, Elliott MD, et al. The impact of adjunctive adenosine infusion during exercise myocardial perfusion imaging: Results of the Both Exercise and Adenosine Stress Test (BEAST) trial. J Nucl Cardiol 2003;10:291-6.
6. Elliott MD, Holly TA, Leonard SM, Hendel RC. Impact of an abbreviated adenosine protocol incorporating adjunctive treadmill exercise on adverse effects and image quality in patients undergoing stress myocardial perfusion imaging. J Nucl Cardiol 2000;7:584-9.
7. Iskandrian AE, Bateman TM, Belardinelli L, Blackburn B, Cerqueira MD, Hendel RC, et al. Adenosine versus regadenoson comparative evaluation in myocardial perfusion imaging: results of the ADVANCE phase 3 multicenter international trial. J Nucl Cardiol 2007;14:645-58.
8. Partington SL, Lanka V, Hainer J, Blankstein R, Skali H, Forman DE, et al. Safety and feasibility of regadenoson use for suboptimal heart rate response during symptom-limited standard Bruce exercise stress test. J Nucl Cardiol 2012;19:970-8.
9. Gibbons RJ, Balady GJ, Bricker JT, Chaitman BR, Fletcher GF, Froelicher VF, et al. American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). Circulation 2002;106:1883-92.
10. Jain M, Nkonde C, Lin BA, Walker A, Wackers FJ. 85% of maximal age-predicted heart rate is not a valid endpoint for exercise treadmill testing. J Nucl Cardiol 2011;18:1026-35.
11. Thomas GS, Thompson RC, Miyamoto MI, Ip TK, Rice DL, Milikien D, et al. The RegEx trial: A randomized, double-blind, placebo- and active-controlled pilot study combining regadenoson, a selective A(2A) adenosine agonist, with low-level exercise, in patients undergoing myocardial perfusion imaging. J Nucl Cardiol 2009;16:63-72.
12. Brown KA, Rowen MA. Impact of antianginal medications, peak heart rate, and stress level on the prognostic value of a normal exercise myocardial perfusion imaging study. J Nucl Med 1993;34:1467-71.
13. Philips L, Wang JW, Pfeffer B, Gianos E, Fisher D, Shaw LJ, et al. Clinical role of the Duke Activity Status Index in the selection of the optimal type of stress myocardial perfusion imaging study in patients with known or suspected ischemic heart disease. J Nucl Cardiol 2011;18:1015-20.